デフォルト表紙
市場調査レポート
商品コード
997979

遺伝子治療市場 - COVID-19の影響分析、市場規模・シェア・予測:2021年~2027年

Gene Therapy Market with COVID-19 Impact Analysis, By Indication, By Vector Type, and By Region - Size, Share, & Forecast from 2021-2027

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 331 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.86円
遺伝子治療市場 - COVID-19の影響分析、市場規模・シェア・予測:2021年~2027年
出版日: 2021年03月01日
発行: AnalystView Market Insights
ページ情報: 英文 331 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子治療市場は、2020年に23億6,000万米ドルに達しました。市場は、今後数年間でかなりの成長率を目撃すると推定されています。先進治療や遺伝子デリバリー技術に対する需要の増加が、市場の成長を促進しています。

当レポートでは、世界の遺伝子治療市場について調査分析し、市場概要、市場力学、セグメント別の市場分析、主要企業などについて、体系的な情報を提供しています。

目次

第1章 遺伝子治療市場概要

第2章 エグゼクティブサマリー

第3章 遺伝子治療市場の主要動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 遺伝子治療業界分析

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • 成長の見通しマッピング
  • 規制の枠組み分析

第5章 遺伝子治療市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 遺伝子治療市場情勢

  • 市場シェア分析
  • 主要イノベーター分析
  • 内訳データ:主要メーカー別

第7章 遺伝子治療市場:適応症別

  • 概要
  • 急性リンパ芽球性白血病(ALL)
  • 遺伝性網膜疾患
  • 大細胞型B細胞リンパ腫
  • ADA-SCID
  • 黒色腫(病変)
  • ベータサラセミアメジャー/SCD
  • 頭頸部扁平上皮がん
  • 末梢動脈疾患
  • 脊髄性筋萎縮症(SMA)
  • その他

第8章 遺伝子治療市場:ベクタータイプ別

  • 概要
  • レンチウイルス
  • AAV
  • レトロウイルス・ガンマレトロウイルス
  • 改変単純ヘルペスウイルス
  • アデノウイルス
  • 非ウイルスプラスミドベクター

第9章 遺伝子治療市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 主要ベンダー分析

  • 競合ダッシュボード
  • 企業プロファイル
    • REGENXBIO, Inc.
    • Oxford BioMedica plc
    • Dimension Therapeutics, Inc.
    • Bristol-Myers Squibb Company
    • SANOFI
    • Applied Genetic Technologies Corporation
    • F. Hoffmann-La Roche Ltd.
    • Bluebird Bio, Inc.
    • Novartis AG
    • Gilead Lifesciences, Inc.
    • Benitec Biopharma Ltd.
    • Gensight Biologics SA
    • Transgene
    • Calimmune, Inc.

第11章 アナリストの見解

第12章 付録

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Gene Therapy market: Indications Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Indications
  • TABLE Global Gene Therapy market, by Indications 2016-2027 (USD Million)
  • TABLE Gene Therapy market: Vector Type Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Vector Type
  • TABLE Global Gene Therapy market, by Vector Type 2016-2027 (USD Million)
  • TABLE Gene Therapy market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Gene Therapy market, by Region 2016-2027 (USD Million)
  • TABLE North America Gene Therapy market, by Country, 2016-2027 (USD Million)
  • TABLE North America Gene Therapy market, by Indications, 2016-2027 (USD Million)
  • TABLE North America Gene Therapy market, by Vector Type, 2016-2027 (USD Million)
  • TABLE Europe Gene Therapy market, by Country, 2016-2027 (USD Million)
  • TABLE Europe Gene Therapy market, by Indications, 2016-2027 (USD Million)
  • TABLE Europe Gene Therapy market, by Vector Type, 2016-2027 (USD Million)
  • TABLE Asia Pacific Gene Therapy market, by Country, 2016-2027 (USD Million)
  • TABLE Asia Pacific Gene Therapy market, by Indications, 2016-2027 (USD Million)
  • TABLE Asia Pacific Gene Therapy market, by Vector Type, 2016-2027 (USD Million)
  • TABLE Latin America Gene Therapy market, by Country, 2016-2027 (USD Million)
  • TABLE Latin America Gene Therapy market, by Indication, 2016-2027 (USD Million)
  • TABLE Latin America Gene Therapy market, by Vector Type, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Gene Therapy market, by Country, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Gene Therapy market, by Indication, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Gene Therapy market, by Vector Type, 2016-2027 (USD Million)

List of Figures

  • FIGURE Gene Therapy market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Indication segment market share analysis, 2020 & 2027
  • FIGURE Indication segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Vector Type segment market share analysis, 2020 & 2027
  • FIGURE Vector Type segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America Gene Therapy market share and leading players, 2019
  • FIGURE Europe Gene Therapy market share and leading players, 2019
  • FIGURE Asia Pacific Gene Therapy market share and leading players, 2019
  • FIGURE Latin America Gene Therapy market share and leading players, 2019
  • FIGURE Middle East and Africa Gene Therapy market share and leading players, 2019
  • FIGURE North America market share analysis by country, 2019
  • FIGURE U.S. Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Canada Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Europe Gene Therapy market share analysis by country, 2019
  • FIGURE Germany Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Spain Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Italy Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE UK Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE France Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of the Europe Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Asia Pacific Gene Therapy market share analysis by country, 2019
  • FIGURE India Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE China Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Japan Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE South Korea Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Singapore Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of APAC Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Gene Therapy market share analysis by country, 2019
  • FIGURE Brazil Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Mexico Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Argentina Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of LATAM Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Gene Therapy market share analysis by country, 2019
  • FIGURE Saudi Arabia Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE United Arab Emirates Gene Therapy market size, forecast and trend analysis, 2016 to 2027 (USD Million)
目次

REPORT HIGHLIGHT

The global Gene Therapy market was valued at USD 2.36 billion in 2020, growing with 21.7 CAGR during the forecast period, 2021-2027.

Gene therapy is a method in which DNA or gene is introduced into a patient for treating genetic diseases. Gene therapy involves repressing, repairing, or replacing dysfunctional genes that cause disease. This therapy is used for the treatment of some genetic diseases such as cystic fibrosis, and muscular dystrophy as well as various inherited disorders, and cancer.

Market Dynamics

The gene therapy market is estimated to witness a substantial growth rate in the next few years. The increasing demand for advanced therapies and gene delivery technology is boosting the market growth. In addition, several market players are engaging in commercializing their therapy products. However, the ongoing COVID-19 pandemic has impacted the research procedures in gene therapies. According to the Office of Tissues & Advanced Therapy in the U.S. FDA, there is no increase in the new drugs application & therapies due to COVID-19. Further, the high cost associated with therapy development may restrain the market growth.

Furthermore, the growing adoption of payment models like health outcome-based and financial-based agreements is boosting the therapies market growth. The cell and gene therapy sector has been impacted by the SARS COV-2 pandemic. Various research & enrollment processes and universities had been shut down thus, clinical trials progress is also slow. On the other hand, pharma companies are collaborating with CMOs to remain competent in the market. For example, in 2020, Univercells has unveiled Exothera, a viral vector CDMO that serves cell & gene therapy developers.

The gene therapy market is segregated into indication and vector type segments. Based on indication, the Spinal Muscular Atrophy (SMA) segment held the largest revenue share of over 40.0% in 2019. By vector type, the AAV type segment is projected to offer potential growth opportunities for the market during the forecast period.

Regional Insights

In 2019, North America held the largest revenue share of over 50.0% in the overall market. With the presence of a large number of pharma companies and a rising focus on R&D development, FDA approvals are boosting regional growth. Europe is projected to expand at a significant rate over the forecast period. The companies in the European market are seeking FDA approval as well after EU approvals to gain traction in the global industry. The Asia Pacific is projected to offer lucrative growth opportunities over the forecast period, 2021 to 2027.

Competitive Landscape

The gene therapy market is moderately competitive in nature. Top players in the market indulge in advancements in gene therapies to enhance their global reach. Key players in the industry include REGENXBIO, Inc., Oxford BioMedica plc, Dimension Therapeutics, Inc., and Bristol-Myers Squibb Company. These players in the market engage in strategic activities such as collaboration, and new product developments to maintain their position in the market. For example, in 2020, REGENXBIO Inc., has collaborated with Ultragenyx Pharmaceutical Inc. for using NAV technology platforms.

Key features of the study:

This proposed research study on Gene Therapy market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Gene Therapy market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Gene Therapy market

Impact of COVID-19 on Gene Therapy market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Gene Therapy market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Gene Therapy market, we have also included competitive landscape and key innovator analysis for the Gene Therapy market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and end-user's attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Gene Therapy market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the Gene Therapy market on global as well as regional level.

The global Gene Therapy market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENE THERAPY MARKET KEY PLAYERS

REGENXBIO, Inc.

Oxford BioMedica plc

Dimension Therapeutics, Inc.

Bristol-Myers Squibb Company

SANOFI

Applied Genetic Technologies Corporation

F. Hoffmann-La Roche Ltd.

Bluebird Bio, Inc.

Novartis AG

Gilead Lifesciences, Inc.

Benitec Biopharma Ltd.

Gensight Biologics S.A.

Transgene

Calimmune, Inc.

GLOBAL GENE THERAPY MARKET, BY INDICATION

Acute Lymphoblastic Leukemia (ALL)

Inherited Retinal Disease

Large B-cell Lymphoma

ADA-SCID

Melanoma (lesions)

Beta-Thalassemia Major/SCD

Head & Neck Squamous Cell Carcinoma

Peripheral Arterial Disease

Spinal Muscular Atrophy (SMA)

Others

GLOBAL GENE THERAPY MARKET, BY VECTOR TYPE

Lentivirus

AAV

Retrovirus & gamma Retrovirus

Modified Herpes Simplex Virus

Adenovirus

Non-viral Plasmid Vector

GLOBAL GENE THERAPY MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. Gene Therapy Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Indication
    • 2.1.2. Market Snippet by Vector Type
    • 2.1.3. Market Snippet by Region
  • 2.2. Competitive Insights

3. Gene Therapy Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Gene Therapy Industry Study

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Gene Therapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Gene Therapy Market Landscape

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. Gene Therapy Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2020 & 2027 (%)
  • 7.2. Acute Lymphoblastic Leukemia (ALL)
  • 7.3. Inherited Retinal Disease
  • 7.4. Large B-cell Lymphoma
  • 7.5. ADA-SCID
  • 7.6. Melanoma (lesions)
  • 7.7. Beta-Thalassemia Major/SCD
  • 7.8. Head & Neck Squamous Cell Carcinoma
  • 7.9. Peripheral Arterial Disease
  • 7.10. Spinal Muscular Atrophy (SMA)
  • 7.11. Others

8. Gene Therapy Market - By Vector Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Vector Type, 2020 & 2027 (%)
  • 8.2. Lentivirus
  • 8.3. AAV
  • 8.4. Retrovirus & gamma Retrovirus
  • 8.5. Modified Herpes Simplex Virus
  • 8.6. Adenovirus
  • 8.7. Non-viral Plasmid Vector

9. Gene Therapy Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Vector Type, 2016 - 2027, (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.3.10. Rest of Europe
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.10.3. Rest of the Europe Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.3.10.4. Rest of the Europe Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.4.10. Rest of APAC
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.10.3. Rest of APAC Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.4.10.4. Rest of APAC Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.5.9. Rest of LATAM
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.9.3. Rest of LATAM Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.5.9.4. Rest of LATAM Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Vector Type, 2016 - 2027 (US$ Million)

10. Key Vendor Analysis

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. REGENXBIO, Inc.
    • 10.2.2. Oxford BioMedica plc
    • 10.2.3. Dimension Therapeutics, Inc.
    • 10.2.4. Bristol-Myers Squibb Company
    • 10.2.5. SANOFI
    • 10.2.6. Applied Genetic Technologies Corporation
    • 10.2.7. F. Hoffmann-La Roche Ltd.
    • 10.2.8. Bluebird Bio, Inc.
    • 10.2.9. Novartis AG
    • 10.2.10. Gilead Lifesciences, Inc.
    • 10.2.11. Benitec Biopharma Ltd.
    • 10.2.12. Gensight Biologics S.A.
    • 10.2.13. Transgene
    • 10.2.14. Calimmune, Inc.

11. 360 Degree AnalystView

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us